|
|
Article: Keratinocyte Growth Factor Differentiates Benign and Cancerous Tumors.
- Article from:
- Angiogenesis Weekly
- Article date:
- January 19, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 JAN 19 - (NewsRx.com) -- Medical investigators in England propose that benign prostatic hyperplasia (BPH) can be distinguished from prostate cancers by testing for a growth factor in the blood called keratinocyte growth factor.
Using typical prostate cancer analysis such as prostate-specific antigen (PSA) testing, tumor staging, and tumor grading, P.B. Mehta et al. of the University of Newcastle Upon Tyne compared 81 men with BPH with 56 men with prostate cancer for the presence of serum keratinocyte growth factor (KGF).
"Serum KGF levels tend to be higher in men with BPH compared to those with prostate cancer (1,242 and 828 pg/ml, respectively)," ...